Notable Movers: (AMEX:PAL), (NYSE:KWK), (NASDAQ:ZG
Post# of 98059
Notable Movers: (AMEX AL), (NYSE:KWK), (NASDAQ:ZGNX), (NASDAQ PHM), (NASDAQ:ONTY)
New York, NY — (NISMAGAZINE) — 01/02/2013 — North American Palladium Ltd (USA) (AMEX AL) shares soared 11.50% at $1.45. The company, on Dec. 13, announced that Mr. Jeffrey Swinoga has resigned as Vice President Finance and Chief Financial Officer, effective January 4, 2013, to pursue a Chief Financial Officer position at another public company. The Company”s finance team has excellent depth and experience to oversee financial management until a new chief financial officer is named.
How Should Investors Trade PAL After Today’s Rally? Find Out Here
Quicksilver Resources Inc (NYSE:KWK) shares increased 2.10% to $2.95. Zacks reissued their neutral rating on shares of Quicksilver in a research report released on Dec. 25. Zacks currently has a $3.50 price target on the stock. Additionally, analysts at Macquarie upgraded shares of Quicksilver Resources from an underperform rating to a neutral rating in a research note to investors on Nov. 16. They now have a $2.50 price target on the stock.
Should Investors Buy KWK After The Latest News? Get Comprehensive Report here
Zogenix, Inc. (NASDAQ:ZGNX) stock climbed 2.26% to $1.36. Last month, U.S. regulators said that ZGNX’s pure hydrocodone painkiller Zohydro may be abused at a greater rate if approved than combination products on the market. Food and Drug Administration staff asked outside advisers in a report today to weigh the effectiveness of the extended- release pill against its risk of abuse.
How To Trade ZGNX After The Recent Momentum? Find Out Here
Peregrine Pharmaceuticals(NASDAQ PHM) shares gained 5.30% to $1.38. Zacks upgraded shares of Peregrine from a neutral rating to an outperform rating in a research report sent to investors last week. The firm currently has $1.50 price target on the stock. The company is a biopharmaceutical company developing monoclonal antibodies for the treatment and diagnosis of cancer.
Get Free Trend Analysis On PPHM Here
Oncothyreon Inc (USA) (NASDAQ:ONTY) shares increased 2.60% to $1.97. The company, on Dec. 19, announced that the pivotal Phase 3 clinical trial of L-BLP25 (formerly referred to as Stimuvax) known as START did not meet its primary endpoint of an improvement in overall survival in patients with unresectable, locally advanced stage IIIA or stage IIIB non-small cell lung cancer (NSCLC). The trial was conducted by Merck Serono, a division of Merck KGaA of Darmstadt, Germany, under a license agreement with Oncothyreon.
Should Investors Buy ONTY at CMP? Get Free Trend Analysis Here
About HotStockProfits.com
Subscribe for FREE to receive our “50 Stock Trading Rules No Hedge Fund Wants You To Know!” E-Book: http://hotstockprofits.com/trade-alert/
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
Disclosure:
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Contact:
Edmund Kaminski
edmundkaminski@gmail.com
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'